SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.800
+0.200 (4.35%)
Jan 6, 2026, 4:00 PM EST - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $325.67 million as of January 6, 2026. Its market cap has increased by 44.17% in one year.
Market Cap
325.67M
Enterprise Value
307.43M
1-Year Change
44.17%
Ranking
Category
Stock Price
$4.80
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $325.67M, a decrease of -70.93%. That is a compound annual growth rate of -24.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 325.67M | 2.78% |
| Dec 31, 2025 | 316.85M | 55.34% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
| Jul 23, 2021 | 1.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |